The antiviral remdesvir has been approved by the US Food and Drug Administration for the treatment of patients hospitalized with Covid 19 , Gilead Sciences announced Thursday . 
The drug , sold under the brand name Veklury , has been used under emergency use authorization ( EUA ) in the US . 
It is the first drug to be approved in the US for treating Covid 19 . 
Some context : Earlier this month , a World Health Organization sponsored global study found remdesivir did not help patients survive or even recover faster , but a US study found the infused drug shortened recovery time for some patients by about a third . 
